BlackRock Investment Management’s Fresh Tracks Therapeutics, Inc. Common Stock FRTX Stock Holding History

BlackRock Investment Management’s Portfolio FRTX Stock Details FRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$4K	Hold	5	–	–	﹤0.01%	3810
2016 Q3	$5K	Hold	5	–	–	﹤0.01%	3787
2016 Q2	$7K	Buy	+5	New	+$6.43K	﹤0.01%	3777
2015 Q2	–	Sell	-4	Closed	-$13K	–	4214
2015 Q1	$13K	Hold	4	–	–	﹤0.01%	3569
2014 Q4	$15K	Hold	4	–	–	﹤0.01%	3538
2014 Q3	$16K	Hold	4	–	–	﹤0.01%	3488
2014 Q2	$17K	Sell	4 -64	-94%	-$241K	﹤0.01%	3453
2014 Q1	$278K	Sell	68 -1	-1%	-$4.46K	﹤0.01%	3182
2013 Q4	$257K	Sell	69 -1	-1%	-$3.79K	﹤0.01%	3183
2013 Q3	$277K	Buy	70 +4	+6%	+$30K	﹤0.01%	3130
2013 Q2	$654K	Buy	+66	New	+$731K	﹤0.01%	2665

Other funds holding FRTX

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return

BlackRock Investment Management's FRTX Position: Q4 2016 in Review

BlackRock Investment Management held its Fresh Tracks Therapeutics, Inc. Common Stock (FRTX) position steady in Q4 2016 at 5 shares worth $4K. The position accounts for ﹤0.01% of the portfolio, ranked #3810.

BlackRock Investment Management first reported a position in FRTX in Q2 2013 and has held it in 11 quarters since. The position peaked at $654K in Q2 2013. 26 funds tracked by Wall St. Rank hold FRTX as of Q4 2016.

BlackRock Investment Management held 5 shares of Fresh Tracks Therapeutics, Inc. Common Stock worth $4K as of Q4 2016.
BlackRock Investment Management left its Fresh Tracks Therapeutics, Inc. Common Stock share count unchanged in Q4 2016.
Fresh Tracks Therapeutics, Inc. Common Stock made up ﹤0.01% of BlackRock Investment Management's portfolio in Q4 2016, its #3810 holding.
BlackRock Investment Management first reported a position in Fresh Tracks Therapeutics, Inc. Common Stock in Q2 2013 and has held it in 11 quarters since.
BlackRock Investment Management's Fresh Tracks Therapeutics, Inc. Common Stock position peaked at $654K in Q2 2013.
26 funds tracked by Wall St. Rank held Fresh Tracks Therapeutics, Inc. Common Stock as of Q4 2016.

Based on BlackRock Investment Management's 13F filing for Q4 2016, filed 10 Feb 2017.